Corporate insider profile

Thomas K Equels Filing Activity

Latest reported as CEO & President of AIM ImmunoTech Inc. (AIM).

Purchase filings: 4
Reported companies: 1
Net open-market value: $13,456
Latest transaction: Sep 17, 2026

Affiliated corporations

Reported company relationships

AIMLatest reported

AIM ImmunoTech Inc.

CEO & President

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
Date	Company	Role	Type	Shares	Price	Total value
Sep 17, 2026	AIM ImmunoTech Inc. (AIM)	CEO & President	Open Market Purchase	24,000	$0.21	$4,992
Sep 16, 2026	AIM ImmunoTech Inc. (AIM)	CEO & President	Open Market Purchase	11,000	$0.21	$2,310
Sep 15, 2026	AIM ImmunoTech Inc. (AIM)	CEO & President	Open Market Purchase	22,000	$0.22	$4,862
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]

🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium